Supplemental material
OncoImmunology
Volume 12, 2023 - Issue 1
Open access
1,587
Views
2
CrossRef citations to date
0
Altmetric
Research paper
A Chemically Defined TLR3 Agonist with Anticancer Activity
Julie Le Naoura Centre de Recherche des Cordeliers, Equipe Labellisée Par la Ligue Contre le Cancer, Paris, France;b Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, FranceView further author information
, Sylvain Thierryc Tollys, Lyon, FranceView further author information
, Sarah Adriana Scuderia Centre de Recherche des Cordeliers, Equipe Labellisée Par la Ligue Contre le Cancer, Paris, France;b Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France;d Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, ItalyView further author information
, Mathilde Boucard-Jourdinc Tollys, Lyon, FranceView further author information
, Peng Liua Centre de Recherche des Cordeliers, Equipe Labellisée Par la Ligue Contre le Cancer, Paris, France;b Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, FranceView further author information
, Marc Bonninc Tollys, Lyon, FranceView further author information
, Yuhong Pana Centre de Recherche des Cordeliers, Equipe Labellisée Par la Ligue Contre le Cancer, Paris, France;b Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, FranceView further author information
, Clémence Perretc Tollys, Lyon, FranceView further author information
, Liwei Zhaoa Centre de Recherche des Cordeliers, Equipe Labellisée Par la Ligue Contre le Cancer, Paris, France;b Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, FranceView further author information
, Misha Maoa Centre de Recherche des Cordeliers, Equipe Labellisée Par la Ligue Contre le Cancer, Paris, France;b Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, FranceView further author information
, Chloé Renouxc Tollys, Lyon, FranceView further author information
, María Pérez-Lanzóna Centre de Recherche des Cordeliers, Equipe Labellisée Par la Ligue Contre le Cancer, Paris, France;b Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, FranceView further author information
, Baptiste Martinc Tollys, Lyon, FranceView further author information
, Oliver Keppa Centre de Recherche des Cordeliers, Equipe Labellisée Par la Ligue Contre le Cancer, Paris, France;b Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, FranceCorrespondence[email protected]
https://orcid.org/0000-0002-6081-9558View further author information
, https://orcid.org/0000-0002-6081-9558View further author information
Guido Kroemera Centre de Recherche des Cordeliers, Equipe Labellisée Par la Ligue Contre le Cancer, Paris, France;b Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France;e Department of Biology, Institut du Cancer Paris CARPEM, Hôpital Européen Georges Pompidou, AP-HP, Paris, FranceCorrespondence[email protected]
https://orcid.org/0000-0002-9334-4405View further author information
& https://orcid.org/0000-0002-9334-4405View further author information
Bettina Werléc Tollys, Lyon, FranceView further author information
show all
Article: 2227510
|
Received 31 Mar 2023, Accepted 15 Jun 2023, Published online: 27 Jun 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.